Menu

Drugmakers recently announced refunds to 340B covered entities that purchased certain drugs between 2023 and 2026, as well as national drug code changes.

Five Drugmakers to Refund 340B Covered Entities for Overcharges, Three Announce NDC Changes

March 12, 2026 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Five drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2023 and 2026, while three unveiled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Shannon Young

Bill Chamerlik, VP of Sales, Proximity Health

Sixth 340B Administrative Dispute Resolution Panel Sides with Drugmaker in Contract Pharmacy Dispute